An update on bisphosphonates and trends in drug therapy for osteoporosis. Osteoporosis in Super-aged society. Suzuki Atsushi 1 1Division of Endocrinology and Metabolism, Fujita Health University School of Medicine, Aichi, Japan. pp.183-187
Published Date 2017/1/28
DOI https://doi.org/10.20837/4201702009
  • Abstract
  • Look Inside
  • Reference

 Osteoporosis could contribute to increase other chronic diseases such as cardiovascular events, resulting in higher mortality in these patients. Antiresorptive agents such as bisphosphonates has been reported to reduce not only the number of fragile fracture but also all causes mortality. These agents are also expected to improve quality of life and activity of daily life with longer life expectancy.


電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社